Addressing insurance‐related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery
Sign Up to like & getrecommendations! Published in 2022 at "Obesity"
DOI: 10.1002/oby.23556
Abstract: The past decade has witnessed significant progress in the development of new antiobesity medications, with several having greater efficacy than pharmacological agents previously approved by the Food and Drug Administration (FDA). Despite the potential of… read more here.
Keywords: antiobesity medications; coverage; insurance; antiobesity ... See more keywords
Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment
Sign Up to like & getrecommendations! Published in 2023 at "Obesity"
DOI: 10.1002/oby.23725
Abstract: Novel antiobesity treatments are highly effective in recent clinical trials. Access to these medications is needed to supplement lifestyle and surgical interventions for millions living with obesity worldwide, but high prices are limiting. This study… read more here.
Keywords: prices lowest; minimum prices; estimated minimum; antiobesity ... See more keywords
Leptin and Adiponectin Signaling Pathways Are Involved in the Antiobesity Effects of Peanut Skin Extract
Sign Up to like & getrecommendations! Published in 2019 at "Oxidative Medicine and Cellular Longevity"
DOI: 10.1155/2019/2935315
Abstract: Excessive food intake and metabolic disorder promote obesity and diabetes. In China, peanut skin is used as a herbal medicine to treat hemophilia, thrombocytopenic purpura, and hepatic hemorrhage. In the present study, we demonstrated that… read more here.
Keywords: medicine; pse; leptin; adiponectin ... See more keywords
The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Endocrinology"
DOI: 10.1155/2021/6616693
Abstract: Objectives Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome (PCOS) patients. However, there was no literature to compare the antiobesity effects of these two medicines.… read more here.
Keywords: overweight obese; meta analysis; glp 1ras; analysis ... See more keywords
Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice
Sign Up to like & getrecommendations! Published in 2020 at "PLoS Biology"
DOI: 10.1371/journal.pbio.3000688
Abstract: Obesity leads to multiple health problems, including diabetes, fatty liver, and even cancer. Here, we report that urolithin A (UA), a gut-microflora–derived metabolite of pomegranate ellagitannins (ETs), prevents diet-induced obesity and metabolic dysfunctions in mice… read more here.
Keywords: urolithin exerts; adipose tissue; browning white; thermogenesis ... See more keywords
Effect of mHealth With Offline Antiobesity Treatment in a Community-Based Weight Management Program: Cross-Sectional Study
Sign Up to like & getrecommendations! Published in 2020 at "JMIR mHealth and uHealth"
DOI: 10.2196/13273
Abstract: Background Weight loss interventions using mobile phone apps have recently shown promising results. Objective This study aimed to analyze the short-term weight loss effect of a mobile coaching intervention when it is integrated with a… read more here.
Keywords: intervention; mhealth; weight loss; study ... See more keywords
Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.984041
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and affects a considerable proportion of the general population worldwide. Obesity is a major risk factor for development and progression of NAFLD and weight… read more here.
Keywords: nonalcoholic fatty; fatty liver; liver disease; antiobesity ... See more keywords
Enhanced Antiobesity Efficacy of Tryptophan Using the Nanoformulation of Dendropanax morbifera Extract Mediated with ZnO Nanoparticle
Sign Up to like & getrecommendations! Published in 2021 at "Materials"
DOI: 10.3390/ma14040824
Abstract: Green synthesis of metal nanoparticles from medicinal plants has provided a broad scope in biomedical research and functional food formulations due to low toxicity. Dendropanax morbifera (DM) is a versatile traditional medicine used for various… read more here.
Keywords: zno; efficacy; dendropanax; dendropanax morbifera ... See more keywords
Copper Ionophores as Novel Antiobesity Therapeutics
Sign Up to like & getrecommendations! Published in 2020 at "Molecules"
DOI: 10.3390/molecules25214957
Abstract: The therapeutic utility of the copper ionophore disulfiram was investigated in a diet-induced obesity mouse model (C57BL/6J background), both through administration in feed (0.05 to 1% (w/w)) and via oral gavage (150 mg/kg) for up… read more here.
Keywords: hepatic copper; disulfiram; copper; copper ionophores ... See more keywords
In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020191
Abstract: This study aims to determine the antiobesity activity of Calophyllum soulattri leaves extract (CSLE) on high fat diet-fed rats (HFD) and to predict the molecular docking and pharmacokinetics of selected compounds of Calophyllum soulattri to… read more here.
Keywords: molecular docking; vivo pharmacodynamics; pharmacodynamics calophyllum; calophyllum soulattri ... See more keywords